Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Mezigdomide and Talquetamab in Relapsed and Refractory Multiple Myeloma

Massachusetts General Hospital · 2025
ClinicalTrials.gov · Datasets · License: Public Domain · 2025
Open Source ↗
relapsed refractory multiple myeloma (rrmm), prior therapy, triple class exposed rrmm, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 905944
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.